Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response

8 Mar 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Computational Drug Discovery Methods
Share to Melanoma and MAPK Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30850937
DOI: 10.1007/s12020-019-01890-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical responsePMID 30850937Read ↗

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting.Semantic proximity Read ↗

Overcoming Resistance to BRAF <sup>V600E</sup> Inhibition in Melanoma by Deciphering and Targeting Personalized Protein Network AlterationsSemantic proximity Read ↗

BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression.Semantic proximity Read ↗

Sample-specific network analysis identifies gene coexpression patterns of immunotherapy response in advanced kidney cancerSemantic proximity Read ↗

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer.Semantic proximity Read ↗

Decoding mTOR signalling heterogeneity in the tumour microenvironment using multiplexed imaging and graph convolutional networksSemantic proximity Read ↗

Gene Expression Profiling in BRAF-Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib.Semantic proximity Read ↗

SWI/SNF Complex Genomic Alterations as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Multiple CancersSemantic proximity Read ↗

A tumor-agnostic, topology-informed scoring framework for drug repurposing: application to CDK4/6 inhibitor resistance in HR+ breast cancerSemantic proximity Read ↗

Path2Surv: Pathway/gene set-based survival analysis using multiple kernel learningSemantic proximity Read ↗

The `dnet’ approach promotes emerging research on cancer patient survivalSemantic proximity Read ↗

Network propagation in the cytoscape cyberinfrastructure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.